Previous 10 | Next 10 |
Recent news releases related news releases and press releases from 08/01/23 07:30:00 on US and Canada Markets.
NEW YORK, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders ...
GAITHERSBURG, Md., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that it has enrolled the first subject in the Phase 2b IMPACT trial evaluating the efficacy and safety of pemvidutide in subjects with non-alcoholic stea...
BRENTWOOD, Tenn., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading provider of surgical services, today announced financial results for the second quarter ended June 30, 2023. Revenues were $667.6 millio...
YAVNE, Israel, Aug. 01, 2023 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully integrated biopharmaceutical company focused on next-generation enzymatic therapeutics for tissue repair, today announced that its strategic partner, Kaken Pharmaceutical Co. Ltd, launched NexoBrid ® ...
Syros Pharmaceuticals (NASDAQ:SYRS), a biopharmaceutical company committed to advancing new standards of care for the frontline treatment of hematologic malignancies, today announced that it will host a live conference call and webcast at 8:30 a.m. ET on Tuesday, August 8, 2023 to report its seco...
SunPower Financial to Become Exclusive Lease and PPA Provider for ADT Solar PR Newswire SunPower Financial to offer low-cost lease and PPA options to ADT Solar customers beginning this year Further establishes SunPower Financial as the solar financier of choice for hom...
All economic and financial indicators grew: Consolidated turnover of € 1.038.9 million (€889.7 in H1 2022); EBITDA of € 153.9 million (€144.4 in H1 2022); EBIT of €123.6 million (€122.9 in H1 2022); Pre-tax profit of ...
HARMONY BIOSCIENCES ANNOUNCES $125 MILLION SHARE REPURCHASE PROGRAM PR Newswire PLYMOUTH MEETING, Pa. , Aug. 1, 2023 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony" or the "Company") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and comme...
All economic and financial indicators grew: Consolidated turnover of € 1.038.9 million (€889.7 in H1 2022); EBITDA of € 153.9 million (€144.4 in H1 2022); EBIT of €123.6 million (€122.9 in H1 2022); Pre-tax profit of ...
Kevin Guest Cites 5 Ways to Celebrate August's Happiness Month Canada NewsWire SALT LAKE CITY , Aug. 1, 2023 /CNW/ -- Throughout August, Kevin Guest , Executive Chairman at USANA Health Sciences (NYSE: USNA) and best-selling author of " All the Right Reason...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
15.61%Change Percent:
Hudson Technologies Inc. Company Name:
HDSN Stock Symbol:
NASDAQ Market:
hudson-technologies.com Website: